| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |